Is US BioTec Inc (USBC) overvalued?
US BioTec Inc (USBC) is a agricultural inputs company listed on US.
This page asks whether US BioTec Inc (USBC) looks expensive on cached numbers — not a short thesis.
Latest reported USBC revenue for 2023-09-30 was $0. Net income was -$15.3M. Revenue was down 100.0% from 2022-09-30 to 2023-09-30. USBC currently screens at market cap $0.
USBC currently screens at market cap $0. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next USBC 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the USBC stock page for the full model, not this heading.
Not investment advice.